Skip to main content
. Author manuscript; available in PMC: 2013 Jun 10.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jun 22;4(11):1816–1824. doi: 10.1158/1940-6207.CAPR-11-0130

Table 1.

Association between EZH2 Expression and Patient Characteristics

EZH2 Expression
Characteristic No. of Patients Weak (0–1) Moderate (2) Strong (3) P
No. % No. % No. %
All patients 76 16 21 26 34 34 45
Age, years
 Mean ± SD 55.1 ± 13.6 52.4 ± 11.1 52.7 ± 13.6 58.1 ± 14.3 .24
 Median 53.5 53.5 51.5 59.0
 Minimum, maximum 25.0, 82.0 28.0, 76.0 25.0, 80.0 28.0, 82.0
Age group
 <60 years 47 11 24 18 38 18 38 .40
 ≥60 years 29 5 17 8 28 16 55
Sex
 Female 34 5 15 13 38 16 47 .48
 Male 42 11 26 13 31 18 43
Histology
 Dysplasia 57 6 11 21 37 30 53 <.001
 Other 19 10 53 5 26 4 21
Anatomic Site
 Low risk areas* 31 11 35 9 29 11 35 .04
 High risk areas* 45 5 11 17 38 25 51
Smoking Status
 Yes 14 4 28 5 36 5 36 .45
 No 51 8 16 17 33 26 51
 Unknown 11 4 36 4 36 3 28
Alcohol ConsumptionStatus
 Yes 17 6 35 6 35 5 30 .09
 No 48 6 13 16 33 26 54
 Unknown 11 4 36 4 36 3 28

Abbreviations: SD, standard deviation; P, p-value of the Kruskal-Wallis test for age as a numeric variable and that of Fisher’s Exact test for age group and other variables.

Other: Non dysplastic OL lesions ( Hyperkeratosis, Acanthosis, and Hyperplasia).

*

Low risk areas: buccal mucosa, labial mucosa, gingiva, and palate. High risk areas: floor of mouth, lateral and ventral tongue.